G protein-coupled receptors (GPCRs) are important classes of cell surface receptors involved in multiple physiological functions. Aberrant expression, upregulation, and mutation of GPCR signaling pathways are frequent in many types of cancers, promoting hyperproliferation, angiogenesis, and metastasis. Recent studies showed that alterations of GPCRs are involved in different lymphoma types. Herein, we review the synthetic strategies to obtain GPCR inhibitors, focusing on CXCR4 inhibitors which represent most of the GPCR inhibitors available in the market or under preclinical investigations for these diseases.
Barreca M., Spano' V., Raimondi M.V., Bivacqua R., Giuffrida S., Montalbano A., et al. (2022). GPCR Inhibition in Treating Lymphoma [10.1021/acsmedchemlett.1c00600].
GPCR Inhibition in Treating Lymphoma
Barreca M.;Spano' V.;Raimondi M. V.;Bivacqua R.;Giuffrida S.;Montalbano A.
;Barraja P.
2022-02-15
Abstract
G protein-coupled receptors (GPCRs) are important classes of cell surface receptors involved in multiple physiological functions. Aberrant expression, upregulation, and mutation of GPCR signaling pathways are frequent in many types of cancers, promoting hyperproliferation, angiogenesis, and metastasis. Recent studies showed that alterations of GPCRs are involved in different lymphoma types. Herein, we review the synthetic strategies to obtain GPCR inhibitors, focusing on CXCR4 inhibitors which represent most of the GPCR inhibitors available in the market or under preclinical investigations for these diseases.
| File | Dimensione | Formato | |
|---|---|---|---|
|
ACS Med. Chem. Lett. 2021.pdf
accesso aperto
Tipologia:
Post-print
Dimensione
1.1 MB
Formato
Adobe PDF
|
1.1 MB | Adobe PDF | Visualizza/Apri |
|
barreca-et-al-2022-gpcr-inhibition-in-treating-lymphoma.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
1.29 MB
Formato
Adobe PDF
|
1.29 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
